Inhaled insulin is a real prescription option for mealtime sugar control, but it is not a needle-free swap for every insulin regimen. Afrezza is regular human insulin as a powder you breathe in at the start of a meal. It carries a boxed warning about sudden airway narrowing in people with chronic lung disease, and everyone needs breathing tests before the first use.
What Afrezza is
Insulin is a 51-amino-acid peptide hormone that moves sugar out of the blood into cells. Afrezza delivers that same human insulin through the lungs instead of under the skin. Per the DailyMed label, it is a rapid-acting mealtime product for people 6 years and older with diabetes. It is not recommended for diabetic ketoacidosis, and it is not recommended in people who smoke or who recently stopped smoking.
MedlinePlus describes the same boxed warning: do not use Afrezza if you have long-term lung problems such as asthma or COPD, because the powder can trigger bronchospasm. A healthcare professional should check how your lungs work before you start.
Lung checks come before the first cartridge
The label requires a medical history, physical exam, and spirometry (FEV1) in every patient before starting, even if you feel fine. Spirometry is repeated after about six months and then yearly, and sooner if you develop wheezing, cough that will not settle, or breathing trouble. A drop of 20% or more in FEV1 from your baseline is a reason to talk with the prescriber about stopping. Cough and throat irritation are among the most common side effects, along with low blood sugar.
The label also notes that a few more lung-cancer cases were seen in Afrezza-treated people than in comparators in trials, with too few events to prove a causal link. If you have a history of lung cancer or high risk, that tradeoff belongs in the conversation before you start.
What this means day to day
- Ask whether you still need a long-acting basal insulin. Afrezza covers meals. Many people still need a separate basal product; do not assume the inhaler replaces every shot.
- Tell the clinic about asthma, COPD, smoking, or recent quitting. Those are stop-or-avoid flags on the label, not fine print.
- Expect breathing tests on a schedule and report new cough, wheeze, or chest tightness promptly.
- Keep a hypoglycemia plan you and people around you understand, the same as with any mealtime insulin.
Inhaled insulin can reduce needle burden for mealtime dosing when lungs are clear and monitoring is in place. It does not erase the need for glucose checks, sick-day rules, or a clinician who knows your full regimen.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against the linked sources (fetched 2026-10-09 PT). Not medical advice.